Ligand validation:3U69

MRD: (4R)-2-METHYLPENTANE-2,4-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3U69_MRD_H_701	34%	83%	0.153	0.835	0.23	0.54	-	-	4	0	100%	1
3U69_MRD_H_700	27%	84%	0.184	0.833	0.39	0.37	-	-	7	0	100%	1
3U8R_MRD_H_606	53%	74%	0.137	0.899	0.3	0.7	-	-	2	0	100%	1
3U8O_MRD_H_606	53%	74%	0.126	0.887	0.47	0.53	-	-	2	0	100%	1
5DO4_MRD_A_101	22%	56%	0.254	0.874	1.23	0.47	1	-	4	0	100%	1
6B6R_MRD_A_307	100%	70%	0.037	0.984	0.6	0.57	-	-	0	0	100%	1
2BJK_MRD_A_1519	100%	71%	0.042	0.985	0.5	0.61	-	-	0	0	100%	1
5SZD_MRD_A_102	98%	93%	0.06	0.984	0.3	0.17	-	-	0	0	100%	1
4DUI_MRD_A_202	98%	59%	0.06	0.982	0.8	0.79	-	-	0	0	100%	1
1SWU_MRD_A_1	97%	67%	0.05	0.967	0.44	0.83	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.